INTRODUCTION
Behcet's disease (BD) is a chronic systemic vasculitis of unknown aetiology characterised by recurrent oral aphthous ulcers, genital ulcers, uveitis, skin lesions, and vasculitis in young adults aged 20e40 years. Abdominal aortic aneurysms (AAAs) associated with BD rapidly increase in diameter and have a high risk of rupture. 1 Open surgical repair is associated with anastomotic pseudoaneurysm in 38.1% and a few case reports of aorto-enteric fistula (AEF). 2e7 It has been postulated that endovascular repair is safer than open repair based on evidence from a case series. A case of AEF after endovascular repair of AAA in a BD patient is reported here and the mechanism and treatment are discussed.
CASE REPORT
A 42 year old man with a confirmed one year diagnosis of BD was admitted with a two day history of abdominal pain. Computed tomography (CT) showed a 5 cm saccular aneurysm 5 cm below the right renal artery and 3 cm above the aortic bifurcation. The diameter of the aorta above and below the aneurysm was 16 mm and 15 mm respectively (Fig. 1A) The C-reactive protein (CRP) level was 124 mg/L. The erythrocyte sedimentation rate (ESR) was 110 mL/hour. The white blood count (WBC) was 11,000/mm 3 and it was assumed that the AAA was a complication of BD. An urgent repair was performed using an off the shelf 20 mm Endurant Iliac tube limb endoprosthesis (ENEW2020C80EE) (Medtronic, Minneapolis, MN) inserted percutaneously via the right common femoral artery. The abdominal pain was resolving and the patient was discharged home 5 days later. Follow up CT scans performed three and six months after the procedure demonstrated a decrease in the size of the aneurysm sac without endoleak, migration, or kinking of the stent graft (Fig. 1B) . The patient had regular follow up visits and controlled his BD with oral prednisolone (60 mg/dL) and colchicine (60 mg/dL).
Thirteen months after repair, the patient was admitted as an emergency with haematemesis and melaena. A CT scan showed migration and kinking of the stent without endoleak (Fig. 1C) . A CT scan with oral contrast showed close contact and loss of the fat streak between the bowel, and air in aneurysm sac (Fig. 1D) . The positive findings in laboratory data were as follows: leukocytosis (WBC, 12,000/ mm 3 ) with predominantly polymorphonuclear leukocytes; ESR of 40 mg/dL and CRP of 35 mg/dL. Endoscopy was performed, but the findings were unremarkable.
A diagnosis of stent graft infection secondary to AEF was confirmed by CT scan (Fig. 1D) . Laparotomy revealed an inflamed aneurysm sac adherent to the jejunum. After proximal infrarenal and distal iliac control was obtained, the aneurysm sac was opened. It was filled with purulent material that was collected for bacteriological examination and culture. A jejunotomy was done to expose the active fistula with the exposed stent graft in the first part of the jejunum. The stent graft was not well incorporated in the aortic wall and was totally explanted. Treatment included extraanatomical axillobifemoral bypass, explantation of the infected stent graft, aneurysm sac debridement, jejunal resection with end to end anastomosis, and omental interposition.
The blood cultures were negative. Bacteroides fragilis and Escherichia coli grew on the intra-operative cultures taken from the endograft; these were treated with intravenous antibiotics (amoxicillin, clavulanic acid, and metronidazole) for 14 days. Histopathology of the AAA specimens showed a fibrotic inflammatory cellular infiltrate with blood clot in the media. There was evidence of an old haemorrhage within the granulation tissue ( Fig. 2A) . The thrombus associated with the fistula wall contained several foci of neutrophil and histiocyte aggregation (Fig. 2B) .
The post-operative course was uncomplicated. The patient was discharged five weeks later in a stable condition on oral prednisolone (60 mg/dL) and colchicine (60 mg/dL) with a regular follow up 3, 6, and 9 months later without any vascular complications.
Consent was obtained from the patient to publish these images and history.
DISCUSSION
Secondary AEF is a rare complication after open AAA repair, occurring in 0.5e1.5% of cases. 2, 3 Regarding management of AAA in BD patients, only a few cases have been reported with AEF after open AAA repair. The incidence is poorly defined (Table 1) . 3e7 AEF after endovascular repair has not been described.
Urgent endovascular repair of an AAA was performed in the patient 13 months previously using the only available off the shelf Endurant iliac tube limb endoprosthesis (Medtronic, Minneapolis, MN, USA), which was 25e30% oversized. The excessive oversizing of the stent graft caused a discrepancy between the aorta above, below, and at the level of the endograft (Fig. 1C) . The pathogenesis of aorto-enteric fistula after endovascular abdominal aortic repair was due to mechanical failure of the stent graft and kinking of the device in the aneurysm sac, which led to aortic graft erosion and pressure necrosis of the bowel wall. 5e7 In addition, aortoenteric fistula was precipitated by inflammatory aortitis after endovascular repair in BD ( Fig. 2A) . Although the aneurysm was focused in one area and the tube graft seemed to be adequate for coverage, the involvement of the aortic wall may have been more extensive than appeared, and more extensive coverage might have been considered with minimal oversizing.
Endovascular AAA repair for a BD patient is less invasive with immediate technical success and anastomotic pseudoaneurysm formation can be avoided. 8 There are also reports of pseudoaneurysm formation at the access site or a recurrent aneurysm at the edge of an inserted stent graft. 8, 9 The patient was treated as an emergency and no preoperative steroid was administered during either the first endovascular repair or the second surgical operation. Adjunctive immunosuppressive therapy may help to prevent recurrence of aneurysm. 9 Some believe immunosuppressive therapy may be useful during the acute inflammatory period and before an operation to reduce the operative complications. 9 Immunosuppressive therapy is not recommended for urgent conditions and severe stent graft infections. Immunosuppressants may increase the risk of complications if not administered properly, and the length of time required for immunosuppressive treatment after surgery remains to be determined. Medical treatment should be tailored to the patient based on their condition and the risk of adverse effects. No guidelines are available regarding immunosuppressant use in BD patients, and there is no consensus; further prospective studies and evaluation on a larger scale are warranted.
The published articles from 1998 to 2016 that report secondary AEF in BD patients after open surgical repair were reviewed along with the patient described here following endovascular repair. The search found five articles with five patients (all men; between 28e45 years of age) ( Table 1) . Secondary AEF was diagnosed from 8 months to 7 2) . Secondary AEF is a serious complication of infected stent grafts. 10 Direct aortic reconstruction was associated with a high mortality rate compared with patients who underwent ABF bypass and graft excision.
Conventional surgical treatment options are associated with high morbidity and mortality and include graft removal with primary or secondary axillobifemoral bypass and graft removal and in situ reconstruction, depending predominantly on the infection status of the surgical site.
Secondary AEF is managed by graft explantation, aortic stump closure, and lower limb revascularisation by axillobifemoral bypass. Primary closure of the aortic defect is considered inadequate, because the infection is not eradicated, and the infected prosthetic graft is not removed. Revascularisation by axillobifemoral bypass has been challenged by the possibility of aortic stump blowout, a risk that also remains during long-term follow up. In situ bypass grafting using homografts, prosthetic or vein grafts should not to be used in grossly infected fields. Prosthetic grafts can have wider application after extensive debridement of the retroperitoneal space, impregnation of the graft with antimicrobials (silver or rifampicin), and omental wrapping. 10 
CONCLUSION
This case demonstrated that AEF is a potential complication of endovascular treatment of AAA for a BD patient. Explantation of the infected graft and axillobifemoral bypass was performed.
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